MGMT and neoplasm: It has been found that the epigenetic silencing of MGMT by promoter hypermethylation can lead to G:C to A:T transition mutations in p53[10], K-ras[11-13], and PIK3CA[11,14], facilitating progression of the tumor to more advanced stages.